Synthetic protease inhibitors for human acute pancreatitis

Japanese Journal of Gastroenterology

Volumn 95, Issue 11, 1998, Pages 1205-1211

  Otani, Taiichi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAMOSTAT MESILATE; GABEXATE; NAFAMSTAT MESILATE; PROTEINASE INHIBITOR;

ACUTE PANCREATITIS; ARTICLE; DRUG EFFECT; DRUG EFFICACY; HUMAN; PROTEINASE INHIBITION;

ACUTE DISEASE; ANIMALS; APROTININ; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; EUROPE; GABEXATE; HUMANS; JAPAN; PANCREATITIS; PROTEASE INHIBITORS; SERINE PROTEINASE INHIBITORS; UNITED STATES;

EID: 0031797597     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bradley III EL, Warshaw AL: Panreatic Abscess. The Pancreas : Biology, Pathobiology, and Disease. 2nd Ed. Go VLW, et al. eds, Raven Press. New York, 1993, 649-663
2. Büchler M, Malfertheiner P, Uhl W. et al: Gabexate mesilate in human acute pancreatitis. Gastroenterology 1993, 104 : 1165-1170
3. Warshaw AL : Damage prevention versus damage control in acute pancreatitis. Gastroenterology 1993, 104 : 1216-1219
4. Cavallini G, Tittobello A, Arulloni L. et al : Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopas creatography. N Engl J Med 1996, 335 : 919-923
5. Steinberg WM, Schlesselman SE : Treatment of acute pancreatitis. Gastroenterology 1987, 93 1420-1427
6. Otani T, Atomi Y, Kuroda A, et al : Distribution of a synthetic protease inhibitor in rat pancreatic acini after supramaximal secretagogue stimulation. Pancreas 1997, 14: 142-149
7. Schmidt J, DelCastillo CF, Rattner DW, et al. Trypsinogen-activation peptides in experimental rat pancreatitis. Gastroenterolgy 1992, 103 : 1009-1016
8. Chepilko SM, Otani T, Gorelick FS, et al : A novel approach to characterize the specificity of antibodies to trypsinogen activation peptide. Pancreas 1997, 15 : 431
9. Otani T, Chepilko SM, Grendell JH, et al : Co-distribution of TAP and the granule membrane protein. GRAMP-92, in rat cerulein-induced pancreatitis. Am J Physiol (in press).
10. Yoshida T : Gabexate mesilate in human acute pancreatitis. Gastroenterology 1993, 105 : 1992-1923
11. Huibregtse K : Complications of endoscopic sphincterotomy and their prevention[editorials] : N Engl J Med 1996, 335 : 961-963
12. Ziebert JJ, Biorkman DJ : Protease inhibitors for prevention of ERCP pancreatitis : can we afford the price of success? Am J Gastroenterol 1997, 92 : 1067-1068
13. Messori A, Rampazzo R, Seroccaro G, et al : Effectiveness of gabexate mesilate in acute pancreatitis - a metaanalysis. Dig Dis Sci 1995, 40 : 734-738
14. Sherman S, Lehman GA : ERCP-and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991, 6 : 350-367
15. Pasricha P : Prevention of ERCP-induced pancreatitis : success at last. Gastroenterology 1997, 112 : 1415-1416
16. Steer ML, Meldolesi J, Figarella C : Pancreatitis-the role of lysosomes. Dig Dis Sci 1984, 29 : 934-938
17. Otani T : Cysteine protease inhibitor. E-64d. prevents in vitro cerulein-induced trypsinogen activation. Gastroenterology 1998, 115 : 802
18. Gorelick FS, Otani T : Mechanisms of intracellular zymogen activation. Clinical Gastroenterology : Acute Pancreatitis. Neoptolemos JP, ed. Baillière Tindall. London (in press).